CEP Q1 2026 Update: CEP 2.0, EDQM’s new guidelines strengthen ecosystem; Indian firms top list of CEPs issued

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Dipropylacetic acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

78 API Suppliers, 35 USDMF, 10 CEP/COS, 3 JDMF, 14 EU WC, 9 KDMF, 16 NDC API, 38 Listed Suppliers

DEVELOPMENTS

25 Drugs in Development

25 Drugs in Development

FINISHED DOSAGE FORMULATIONS

319 FDF Dossiers, 111 FDA Orange Book, 109 Europe, 17 Canada, 26 Australia, 19 South Africa, 37 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SYRUP;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - EQ 125MG VALPROIC ACID, TABLET, DELAYED RELEASE;ORAL - EQ 250MG VALPROIC ACID, TABLET, DELAYED RELEASE;ORAL - EQ 500MG VALPROIC ACID, CAPSULE, DELAYED REL PELLETS;ORAL - EQ 125MG VALPROIC ACID, TABLET, EXTENDED RELEASE;ORAL - EQ 250MG VALPROIC ACID, TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID

RELATED EXCIPIENT COMPANIES

12 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 1 Pharm-RX Chemical, 11 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 5 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 4 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 3 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 1 Avesta Pharma, 38 BASF, 1 CD Formulation, 2 Clariant, 18 Corel Pharma Chem, 6 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 2 Finar, 13 Gangwal Chemicals, 1 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 14 Ideal Cures, 5 Ingredion Pharma Solutions, 23 Kerry, 3 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 18 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 27 Roquette, 14 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 2 Ulanqab Kema New Material, 3 Valens Pharmachem, 4 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

89 Fillers, Diluents & Binders, 82 Coating Systems & Additives, 46 Controlled & Modified Release, 45 Disintegrants & Superdisintegrants, 44 Solubilizers, 44 Direct Compression, 38 Granulation, 37 Taste Masking, 33 Thickeners and Stabilizers, 30 Film Formers & Plasticizers, 23 Parenteral, 22 Topical, 21 Lubricants & Glidants, 20 Chewable & Orodispersible Aids, 16 Co-Processed Excipients, 12 Emulsifying Agents, 11 API Stability Enhancers, 9 Empty Capsules, 7 Surfactant & Foaming Agents, 6 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

2 Data Compilation #PharmaFlow, 63 News #PharmaBuzz

GLOBAL SALES INFORMATION

43 US Medicaid Prescriptions, 63 Regulatory FDF Prices, 5 Annual Reports

MARKET PLACE

30 APIs, 16 FDF Dossiers

REF. STANDARDS & IMPURITIES

2 EDQM, 15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Name of the Firm	Written Confirmation No.	Product Name	Issue Date	Valid Till	Address of the Firm
13/04/2026	Maithri Drugs	India	M/s Maithri Drugs Private Limited	WC-0407	Divalproex Sodium USP	2024-02-12	2027-02-11	Sy. No. 205, 222 to 226, IDA Bonthapally, Bonthapally (Village), Gummadidala (Mandal), Sangareddy -502313, Telangana State, India
23/12/2025	Anjan Drug Private Limited	India	M/s Anjan Drugs Private limited	WC-210	Divalproex Sodium USP	2025-12-17	2028-11-21	Plot No.109,110,115 &116, SIDCO Pharmaceutical Industrial Estate, Alathur-603 110, Old Mamallapuram Road, TamilNadu, India

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Dipropylacetic Acid

Dipropylacetic acid

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

78 API Suppliers

35 USDMF

10 CEP/COS

3 JDMF

14 EU WC

9 KDMF

16 NDC API

38 Listed Suppliers

DEVELOPMENTS

25 Drugs in Development

FINISHED DOSAGE FORMULATIONS

319 FDF Dossiers

111 FDA Orange Book

109 Europe

17 Canada

26 Australia

19 South Africa

37 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SYRUP;ORAL - 250MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - EQ 125MG VALPROIC ACID

TABLET, DELAYED RELEASE;ORAL - EQ 250MG VALPROIC ACID

TABLET, DELAYED RELEASE;ORAL - EQ 500MG VALPROIC ACID

CAPSULE, DELAYED REL PELLETS;ORAL - EQ 125MG VALPROIC ACID

TABLET, EXTENDED RELEASE;ORAL - EQ 250MG VALPROIC ACID

TABLET, EXTENDED RELEASE;ORAL - EQ 500MG VALPROIC ACID

RELATED EXCIPIENT COMPANIES

12 Evonik

2 Rochem International Inc

20 SPI Pharma

1 Pharm-RX Chemical

11 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

2 Pfanstiehl

5 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

3 Dr. Paul Lohmann GmbH & Co. KGaA

4 ACG Worldwide

8 Actylis

1 Aeon Procare

3 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

1 Avesta Pharma

38 BASF

1 CD Formulation

2 Clariant

18 Corel Pharma Chem

6 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

2 Finar

13 Gangwal Chemicals

1 Gloria Interchem

1 Huzhou Sunflower Pharmaceutical

14 Ideal Cures

5 Ingredion Pharma Solutions

23 Kerry

3 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

18 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

5 Novo Excipients

4 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

2 Qualicaps

CAPSULE;ORAL - 250MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SYRUP;ORAL - 250MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons